Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs

Journal of Virological Methods

Volumn 147, Issue 1, 2008, Pages 143-150

  Yao, Qingxia ^a   Qian, Ping ^a   Huang, Qinfeng ^a   Cao, Yi ^a   Chen, Huanchun ^a  

^a State Key Laboratory of Agricultural Microbiology   (China)

Author keywords

Antibody response; Cellular immune response; Foot and mouth disease; Genetically engineered vaccine

Indexed keywords

ANTIGEN; CAPSID PROTEIN; EPITOPE; PLASMID DNA; PROTEIN FHG; PROTEIN P12A3C; PROTEIN PRECURSOR; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA VECTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FHG GENE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENE INSERTION; GENETIC ENGINEERING; GUINEA PIG; IMMUNE RESPONSE; IMMUNOGENICITY; INOCULATION; LYMPHOCYTE PROLIFERATION; MALE; MODIFIED LIVE PSEUDORABIES VIRUS; NONHUMAN; P12A3C GENE; PRIORITY JOURNAL; PSEUDORABIES HERPETOVIRUS; SEROTYPE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENETIC ENGINEERING; GENETIC VECTORS; GUINEA PIGS; HERPESVIRUS 1, SUID; LYMPHOCYTE ACTIVATION; NEUTRALIZATION TESTS; PLASMIDS; VACCINES, DNA; VIRAL VACCINES;

CAVIA; EUKARYOTA; FOOT-AND-MOUTH DISEASE VIRUS; MIRIDAE; SUID HERPESVIRUS 1;

EID: 37149049865     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.08.027     Document Type: Article

References (46)

1. Balamurugan V., Renji R., Saha S.N., Reddy G.R., Gopalakrishna S., and Suryanarayana V.V. Protective immune response of the capsid precursor polypeptide (P1) of foot and mouth disease virus type 'O' produced in Pichia pastoris. Virus Res. 92 (2003) 141-149
2. Barterling S.J. Development and performance of inactivated vaccines against foot and mouth disease. Rev. Sci. Tech. 21 (2002) 577-588
3. Beard C., Ward G., Rieder E., Chinsangaram J., Grubman M.J., and Mason P.W. Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. J. Biotechnol. 73 (1999) 243-249
4. Benvenisti L., Rogel A., Kuznetzova L., Bujanover S., Becker Y., and Stram Y. Gene gun-mediated DNA vaccination against foot-and-mouth disease virus. Vaccine 19 (2001) 3885-3895
5. Bittle J.L., Houghen R.A., Alexander H., Shinnick T.M., Sutcliffe J.G., Lerner R.A., Rowlands D.J., and Brown F. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298 (1983) 30-33
6. Bouma A. Determination of the effectiveness of Pseudorabies marker vaccines in experiments and field trials. Biologicals 33 4 (2005) 241-245
7. Capozzo A.V., Periolo O.H., Robiolo B., Seki C., LaTorre J.L., and Grigera P.R. Total and isotype humoral responses in cattle vaccinated with foot-and-mouth disease virus (FMDV) immunogen produced either in bovine tongue tissue or in BHK-21 cell suspension cultures. Vaccine 15 (1997) 624-630
8. + mutant of pseudorabies virus Ea strain. Chin. J. Virol. 7 (2001) 9-14
9. Chinsangaram J., Beard C., Mason P., Zeller M.K., Gordon W., and Grubman J.G. Antibody-response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid-proteins. J. Virol. 72 (1998) 4454-4457
10. Collen T., and Doel T.R. Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes. J. Gen. Virol. 71 (1990) 309-315
11. Crowther J.R., Farias S., Carpenter W.C., and Samuel A.R. Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J. Gen. Virol. 74 14 (1993) 1547-1553
12. Domingo E., Baranowski E., Escarmis C., and Sobrino F. Foot-and-mouth disease virus. Comp. Immunol. Microbiol. Infect. Dis. 25 (2002) 297-308
13. Fang L., Chen H., Xiao S., Wang G., and Ma X. Construction of a universal transfer vector deleting gG of pseudorabies virus. J. Huazhong. Agric. Univ. 20 4 (2001) 306-309
14. Ferrari M., Mettenleiter T.C., Romanelli M.G., Cabassi E., Corradi A., Dal Mas N., and Silini R. A comparative study of pseudorabies virus (PRV) strains with defects in thymidine kinase and glycoprotein genes. J. Comp. Pathol. 123 2-3 (2000) 152-163
15. Filgueira M.P., Wigdorovitz A., Romera A., Zamorano P., Borca M.V., and Sadir A.M. Detection and characterization of functional T-cell epitopes on the structural proteins VP2, VP3, and VP4 of foot and mouth disease virus O1 Campos. Virology 271 (2000) 234-239
16. Firkins L.D., Weigel R.M., Biehl L.G., and Hahn E.C. Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E. Am. J. Vet. Res. 58 9 (1997) 976-984
17. Golding S.M., Hedger R.S., and Talbot P. Radial immuno-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular disease. Res. Vet. Sci. 20 (1976) 142-147
18. Grubman M.J., and Baxt B. Foot-and-mouth disease. Clin. Microbiol. Rev. 17 (2004) 465-493
19. Hong W.Z., Xiao S.B., Zhou R., Fang L.R., He Q.G., Wu B., Zhou F.C., and Chen H.C. Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets. Vaccine 20 (2002) 1205-1214
20. Ju C., Fan H., Tan Y., Liu Z., Xi X., Cao S., Wu B., and Chen H. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2. Vet. Microbiol. 109 (2005) 179-190
21. Kerr F.R., and Harmon B.V. Definition and incidence of apoptosis: an historical perspective. In: Tomei L.D., and Cope F.O. (Eds). Apoptosis: The Molecular Basis of Cell Death (1991), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 5-29
22. Kitson J.D., McCahon D., and Belsham G.J. Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 179 1 (1990) 26-34
23. Li, X.M., 2004. Construction of infectious clone of foot-and-mouth disease virus O/ES/2001 strain and the study of apoptosis induced by pseudorabies virus Ea strain. Doctoral Degree Thesis. Huazhong Agricultural University, p. 71.
24. McCullough K.C., De Simone F., Brocchi E., Capucci L., Crowther J.R., and Kihm U. Protective immune response against foot-and-mouth disease. J. Virol. 66 (1992) 1835-1840
25. Moraes M.P., Mayr G.A., Mason P.W., and Grubman M.J. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 20 (2002) 1631-1639
26. Moraes M.P., Chinsangaram J., Brum M.C., and Grubman M.J. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 22 (2003) 268-279
27. Morgan D.O., and Moore D.M. Protection of cattle and swine against foot and mouth disease using biosynthetic peptide vaccines. Am. J. Vet. Res. 51 (1990) 40-45
28. Parida S., Oh Y., Reid S.M., Cox S.J., Statham R.J., Mahapatra M., Anderson J., Barnett P.V., Charleston B., and Paton D.J. Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV. Vaccine 24 (2006) 965-969
29. Qian, P., 2005. Studies on genetic engineering vaccine and differentiate diagnosis kit. Postdoctor Research Report of Huazhong Agricultural University, pp. 33-42
30. Qian P., Li X.M., Chen H.C., Jin M.L., and He Q.G. Construction of the recombinant pseudorabies virus expressing the GP3 gene of porcine reproductive and respiratory syndrome virus. Chin. J. Biochem. Mol. Biol. 19 3 (2003) 391-395
31. Qian P., Li X.M., Jin M.L., Peng G.Q., and Chen H.C. An approach to an FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody response on FMD and pseudorabies in swine. Vaccine 22 17-18 (2004) 2129-2136
32. Qiu H.J., Tian Z.J., Tong G.Z., Zhou Y.J., Ni J.Q., Luo Y.Z., and Cai X.H. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets. Vet. Immunol. Immunopathol. 106 (2005) 309-319
33. Rieder E., Henry T., Duque H., and Baxt B. Analysis of a foot-and-mouth disease virus yype A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle. J. Virol. 79 (2005) 12989-12998
34. Rodriguez L.L., Barrera J., Kramer E., Lubroth J., Brown F., and Golde W.T. A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine 21 (2003) 3751-3756
35. Saiz J.C., Rodriguez A., Gonzalez M., Alonso F., and Sobrino F. Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins. J. Gen. Virol. 73 (1992) 2601-2607
36. Saiz M., Nunez J.I., Jimenez-Clavero M.A., Baranowski E., and Sobrino F. Foot-and-mouth disease virus: biology and prospects for disease control. Microbes Infect. 4 (2002) 1183-1192
37. Salt J.S. The carrier state in foot and mouth disease-an immunological review. Br. Vet. J. 149 (1993) 207-223
38. Sanz-Parra A., Jimenez-Clavero M.A., Garcia-Briones M.M., Blanco E., Sobrino F., and Ley V. Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology 259 (1999) 129-134
39. Sutmoller P., Barteling S.S., Olascoaga R.C., and Sumption K.J. Control and eradication of foot-and-mouth disease. Virus Res. 91 1 (2003) 101-144
40. Volpina O.M., Surovoy A.Y., Zhmak M.N., Kuprianova M.A., Koroev D.O., Chepurkin A.V., Toloknov A.S., and Ivanov V.T. A peptide construct containing B cell and T cell epitopes from the foot-and-mouth disease viral VP1 protein induces efficient antiviral protection. Vaccine 17 (1999) 577-584
41. Weigel R.M., Hahn E.C., and Scherba G. Survival and immunization of raccoons after exposure to pseudorabies (Aujeszky's disease) virus gene-deleted vaccines. Vet. Microbiol. 92 (2003) 19-24
42. Wigdorovitz A., Zamorano P., Borca M.V., and Sadir A.M. Modulation of the antigen presentation activity in foot and mouth disease virus (FMDV) vaccines by two adjuvants: avridine and a water soluble fraction of Mycobacterium sp. Vaccine 16 (1998) 1627-1632
43. Wong H.T., Cheng S.C., Chan E.W., Sheng Z.T., Yan W.Y., Zheng Z.X., and Xie Y. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Virology 278 (2000) 27-35
44. Wu Q., Moraes M.P., and Grubman M.J. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine. Virus Res. 93 (2003) 211-219
45. Yao Q., Qian P., Guo D., He Y., and Chen H. Fusion expression of immunological epitopes from VP1-3 of foot-and-mouth disease virus with porcine interferon-gamma. Chin. J. Prev. Vet. Med. 29 5 (2007) 346-349
46. Zhang H.Y., Sun S.H., Guo Y.J., Zhou F.J., Chen Z.H., Lin Y., and Shi K. Immune response in mice inoculated with plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus. Vaccine 21 (2003) 4704-4707